AFREZZA

Brand name authorized in: Brazil United States

Active ingredients

The drug AFREZZA contains one active pharmaceutical ingredient (API):

1 Insulin (human)
UNII 1Y17CTI5SR - INSULIN HUMAN

The blood glucose lowering effect of insulin is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver.

Read about Insulin (human)

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
Structured Product Labeling (SPL/PLR)
US

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
BR
Câmara de Regulação do Mercado de Medicamentos
Identifier(s): 574519100000407, 574519100000507, 574519100000607, 574519100000707, 574519100000807, 574519100000907
US
FDA, National Drug Code
Identifier(s): 47918-874, 47918-878, 47918-891